Correlation Between Palisade Bio and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Agios Pharm, you can compare the effects of market volatilities on Palisade Bio and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Agios Pharm.

Diversification Opportunities for Palisade Bio and Agios Pharm

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Palisade and Agios is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Palisade Bio i.e., Palisade Bio and Agios Pharm go up and down completely randomly.

Pair Corralation between Palisade Bio and Agios Pharm

Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Agios Pharm. In addition to that, Palisade Bio is 3.33 times more volatile than Agios Pharm. It trades about -0.01 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.06 per unit of volatility. If you would invest  3,032  in Agios Pharm on August 27, 2024 and sell it today you would earn a total of  2,536  from holding Agios Pharm or generate 83.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Palisade Bio  vs.  Agios Pharm

 Performance 
       Timeline  
Palisade Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Palisade Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Agios Pharm 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.

Palisade Bio and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Palisade Bio and Agios Pharm

The main advantage of trading using opposite Palisade Bio and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Palisade Bio and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios